Astellas Pharma

Dedicated to the development of high-quality peer-reviewed publications covering Astellas products that are compliant with applicable regulations and guidance.

Launch date

1894

Employees

10001+ people

Market cap

Enterprise valuation

€23.9b (Public information from Sep 2024)

Tokyo Japan (HQ)

https://www.astellas.com/

https://twitter.com/astellaspubs https://www.linkedin.com/company/astellaspharmainc/https://apps.apple.com/app/id668006011 https://play.google.com/store/apps/details?id=astellas.com.mmauc.update

Corporate Venture Fund: Astellas Venture

Revenues, earnings & profits over time

JPY	2021	2022	2023	2024	2025	2026	2027
Revenues	1.2t	1.3t	1.5t	1.6t	1.8t	1.8t	1.9t
% growth	(4 %)	4 %	17 %	6 %	9 %	4 %	7 %
EBITDA	220.3b	217.3b	246.7b	185.1b	324.1b	389.6b	465.5b
% EBITDA margin	18 %	17 %	16 %	12 %	19 %	21 %	24 %
Profit	120.6b	124.1b	98.7b	17.0b	78.4b	141.4b	214.6b
% profit margin	10 %	10 %	7 %	1 %	4 %	8 %	11 %
EV / revenue	2.3x	2.5x	2.0x	1.6x	2.1x	2.0x	1.8x
EV / EBITDA	12.8x	14.7x	12.2x	14.1x	11.6x	9.6x	7.7x
R&D budget	224.5b	246.0b	276.1b	294.2b	-	-	-
R&D % of revenue	18 %	19 %	18 %	18 %	-	-	-